Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification
暂无分享,去创建一个
G. Lin | T. Lue | Ching‐Shwun Lin | X. Qiu | Haiyang Zhang | T. Fandel | H. Orabi | Guifang Wang | L. Ferretti | L. Banie | A. Wu
[1] H. Akiyama,et al. Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development , 2013, Proceedings of the National Academy of Sciences.
[2] G. Lin,et al. Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction. , 2011, European urology.
[3] Eric Chung,et al. Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction. , 2011, The journal of sexual medicine.
[4] G. Brock,et al. Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature , 2011, International Journal of Impotence Research.
[5] N. Gonzalez-Cadavid. Mechanisms of penile fibrosis. , 2009, The journal of sexual medicine.
[6] A. Bottaro,et al. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. , 2009, Molecular endocrinology.
[7] T. Lue,et al. Peyronie’s disease: Past, present, future? , 2008, Current urology reports.
[8] J. Catania,et al. Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls. , 2008, The journal of sexual medicine.
[9] S. Park,et al. Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease. , 2008, International journal of andrology.
[10] N. Longo,et al. A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. , 2008, The international journal of biochemistry & cell biology.
[11] A. Bella,et al. Continuing Medical Education: Peyronie's Disease (CME) , 2007 .
[12] A. Bella,et al. Peyronie's disease (CME). , 2007, The journal of sexual medicine.
[13] T. Diemer,et al. A critical analysis of nonsurgical treatment of Peyronie's disease. , 2006, European urology.
[14] J. Marinković,et al. Risk factors for Peyronie's disease: a case‐control study , 2006, BJU international.
[15] J. Rajfer,et al. Evidence That Osteogenic Progenitor Cells in the Human Tunica Albuginea May Originate from Stem Cells: Implications for Peyronie Disease1 , 2005, Biology of reproduction.
[16] J. Rajfer,et al. Gene Transfer of Inducible Nitric Oxide Synthase Complementary DNA Regresses the Fibrotic Plaque in an Animal Model of Peyronie's Disease1 , 2004, Biology of reproduction.
[17] A. Qian,et al. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. , 2004, Urology.
[18] J. Zargooshi. Trauma as the cause of Peyronie's disease: penile fracture as a model of trauma. , 2004, The Journal of urology.
[19] Stephen A Boorjian,et al. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. , 2004, The Journal of urology.
[20] T. Shankey,et al. Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease , 2004, International Journal of Impotence Research.
[21] S. Minhas,et al. The management of Peyronie's disease , 2004, BJU international.
[22] H. Hackstein,et al. Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease. , 2003, The Journal of urology.
[23] J. Mulhall. Expanding the paradigm for plaque development in Peyronie's disease , 2003, International Journal of Impotence Research.
[24] M. Ferrini,et al. Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease , 2003, BJU international.
[25] T. Shankey,et al. Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses , 2002, International Journal of Impotence Research.
[26] J. Rajfer,et al. Gene expression profiles in the Peyronie's disease plaque. , 2002, Urology.
[27] D. Ralph,et al. The Lue procedure: an analysis of the outcome in Peyronie's disease , 2002, BJU international.
[28] T. H. Klotz,et al. The prevalence of Peyronie's disease: results of a large survey , 2001, BJU international.
[29] A Gefen,et al. A biomechanical model of Peyronie's disease. , 2000, Journal of biomechanics.
[30] W. Hellstrom,et al. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. , 2000, The Journal of urology.
[31] R. Moreland. Stimulation of collagen production in an in vitro model for Peyronie’s Disease , 2000, International Journal of Impotence Research.
[32] T. Lue,et al. Histological and ultrastructural alterations in an animal model of Peyronie's disease. , 1998, British journal of urology.
[33] R. Dahiya,et al. An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. , 1997, The Journal of urology.
[34] A. Rearden,et al. Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology. , 1996, The Journal of urology.
[35] L. Sandberg,et al. Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease. , 1994, The Journal of urology.
[36] G. Mueller‐Eckhardt,et al. HLA antigens in Peyronie's disease. , 1994, Urologia internationalis.
[37] J. W. Mcroberts,et al. Peyronie's disease. , 1969, Surgery, gynecology & obstetrics.